01 ALMUS Srl (1)
02 BIOPHARMA Srl (2)
03 C.T. LAB.FARMACEUTICO Srl (3)
04 DOC GENERICI Srl (2)
05 EG SpA (1)
06 ESSETI FARMACEUTICI Srl (1)
07 F.I.R.M.A. SpA (2)
08 FG Srl (1)
09 FRESENIUS KABI ITALIA Srl (3)
10 GENETIC SpA (1)
11 GLAXOSMITHKLINE SpA (7)
12 GlaxoSmithKline AG (3)
13 GlaxoSmithKline leads AS (3)
14 HOSPIRA (4)
15 I.B.N. SAVIO Srl (1)
16 Labatec Pharma SA (3)
17 MIP Pharma GmbH (2)
18 MYLAN SpA (1)
19 PENSA PHARMA SpA (1)
20 S.F.GROUP Srl (2)
21 SANDOZ SpA (1)
22 SIGMATAU GENERICS SpA (1)
23 SIGMATAU IND.FARM.RIUNITE SpA (5)
24 SO.SE.PHARM Srl (4)
25 Stragen Nordic A/S (3)
26 The Fresenius Kabi Norge AS - Halden (3)
27 Villerton Invest Said (3)
28 Blank (2)
01 CEFTAZIDIME (4)
02 Ceftazidime (62)
01 Italy (40)
02 Norway (14)
03 Spain (2)
04 Switzerland (6)
05 USA (4)
01 Ceftazidima 1.000Mg 1 Unit Parenteral Use (21)
02 Ceftazidima 1.000Mg 1 Unit Parenteral Use Ev (6)
03 Ceftazidima 1.000Mg 10 Units Parenteral Use Im Ev (1)
04 Ceftazidima 2.000Mg 1 Unit Parenteral Use Ev (6)
05 Ceftazidima 250Mg 1 Unit Parenteral Use (2)
06 Ceftazidima 500Mg 1 Unit Parenteral Use (4)
07 INJECTABLE;INJECTION (4)
08 Injection (2)
09 Powder for injection fluid, resolution (6)
10 Powder for injection/infusion fluid, resolution (8)
11 Blank (6)